Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeHealth

      Health

      DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease
      Health

      DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease

      August 25, 2026
      Fifth Circuit Rejects “Ghost Rates” in Federal QPA Calculations Under the No Surprises Act
      Health

      Fifth Circuit Rejects “Ghost Rates” in Federal QPA Calculations Under the No Surprises Act

      August 25, 2026
      CDT Announces Investment in Pep’d, Expanding into the Fast-Growing US Peptide Market
      Health

      CDT Announces Investment in Pep’d, Expanding into the Fast-Growing US Peptide Market

      August 25, 2026
      Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
      Health

      Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules

      August 25, 2026
      FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients
      Health

      FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients

      August 25, 2026
      Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
      Health

      Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff

      August 22, 2026
      Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
      Health

      Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      August 22, 2026
      Aveanna Announces Pricing of Secondary Offering of Common Stock
      Health

      Aveanna Announces Pricing of Secondary Offering of Common Stock

      August 21, 2026
      HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK
      Health

      HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK

      August 20, 2026
      Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
      Health

      Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

      August 20, 2026
      1 2 3 … 217 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026